Related Experiment Video
Updated: Feb 22, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
9.2K
Summary
Researchers presented preliminary precision medicine trial results matching patients with approved drugs to tumor mutations. This approach offers new treatment options for patients with rare cancers or those who have exhausted standard therapies.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Standard cancer therapies are often ineffective for rare cancers or patients with advanced disease.
- Precision medicine offers a targeted approach by matching treatments to individual tumor characteristics.
Purpose of the Study:
- To present preliminary results from a multiarm precision medicine trial.
- To evaluate the potential of matching patients with approved drugs based on tumor mutations and tissue type.
Main Methods:
- A multiarm precision medicine trial was conducted.
- Patient treatment was determined by matching tumor mutations and tissue type with approved drugs.
Main Results:
- Preliminary results from the trial were presented.
- The trial demonstrated the potential to identify novel treatment strategies.
Conclusions:
- Precision medicine trials matching drugs to tumor mutations show promise.
- This approach may provide new therapeutic avenues for patients with limited options, including those with rare cancers.
Related Concept Videos
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
177
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
177
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:22Dose-Response Relationship: Potency and Efficacy
6.7K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.7K
01:27Combined Effects of Drugs: Synergism
7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.0K